KC 11458

Drug Profile

KC 11458

Alternative Names: KC11458

Latest Information Update: 12 Jul 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Solvay
  • Class
  • Mechanism of Action Motilin stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Gastro-oesophageal reflux; Gastrointestinal disorders

Most Recent Events

  • 12 Jul 2007 Discontinued - Phase-II for Gastro-oesophageal reflux in Belgium (unspecified route)
  • 12 Jul 2007 Discontinued - Phase-II for Gastro-oesophageal reflux in USA (unspecified route)
  • 11 Oct 2004 A clinical study has been added to the Digestive System Disorders pharmacodynamics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top